Biosidus
Biosimilars Development and Emerging Market Regional Direct Sales – Innovator
Goals & Objectives
Biosidus is an Argentinian innovator and manufacturer of biosimilars. For over 40 years, the company has built a business model around commercializing and distributing biosimilar therapeutics in Latin America and other emerging markets. With their 10th biosimilar on the verge of commercial approval, Biosidus looked to reposition itself by investing in a more polished brand that would resonate with English-speaking audiences.
Strategic Approach
The strategy for Biosidus’s repositioning centered upon shifting the company’s focus from purely drug manufacturing. This meant emphasizing the impact their products have on the lives of patients worldwide, particularly in underserved markets with developing economies.
Meeting & Exceeding KPIs
Biosidus’s video and thought leadership campaigns created a brand presentation that is much more reflective of the life-changing innovation its products deliver for patients. To date, Biosidus serves 53 distinct emerging markets, with filings in place to expand to 7 more.
